cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
BioRegenEx · Research

How to Evaluate an MSC Exosome Supplier: A Checklist

← Back to Research Library

Choosing a supplier of research-grade MSC exosomes is a due-diligence exercise, not a leap of faith. The right questions are answerable with documents. Use this checklist to compare suppliers objectively. It is provided for educational and research purposes only.

1. Sourcing and ethics

Ask where the cells come from. Ethically obtained, donor-consented, and screened Wharton’s jelly MSCs are a clean, well-documented starting point. The source should be transparent, not vague.

2. Manufacturing standards

Look for a cGMP-aligned process and facility registration — described honestly, not misrepresented as FDA approval.

3. Per-lot, third-party COA

Insist on a Certificate of Analysis for every lot, ideally from an independent lab, reporting particle count, size, identity, purity, and sterility.

4. Honest regulatory labeling

A credible supplier labels its products clearly as Research Use Only and avoids disease-treatment claims. Honest labeling is a signal of a trustworthy partner.

5. Storage, handling, and support

Clear storage and cold-chain instructions, responsive support, and traceable documentation round out a dependable supplier.

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease and are supplied for research use only. This content is for educational and informational purposes and does not constitute medical advice.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.